aTyr Pharma (LIFE) Tops Q4 EPS by 22c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $10.4 thousand versus the consensus estimate of $416.67 thousand.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Enerflex extends revolving credit facility to 2029, ups limit
• JPMorgan and Goldman raise dividends after Fed stress tests